Tyler-Stone Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.57M Sell
64,772
-1,681
-3% -$39.2K 0.25% 77
2025
Q1
$1.68M Buy
66,453
+21,984
+49% +$575K 0.3% 67
2024
Q4
$1.18M Buy
44,469
+13,313
+43% +$361K 0.21% 86
2024
Q3
$902K Buy
31,156
+14,352
+85% +$419K 0.17% 118
2024
Q2
$470K Sell
16,804
-239
-1% -$6.58K 0.19% 99
2024
Q1
$473K Buy
17,043
+1,102
+7% +$30.6K 0.21% 99
2023
Q4
$459K Sell
15,941
-821
-5% -$24.8K 0.23% 89
2023
Q3
$556K Sell
16,762
-485
-3% -$17.2K 0.32% 64
2023
Q2
$633K Buy
+17,247
New +$671K 0.36% 62
2022
Q4
$999K Sell
19,491
-15,947
-45% -$765K 0.68% 35
2022
Q3
$1.55M Sell
35,438
-18,154
-34% -$882K 1.18% 20
2022
Q2
$2.81M Sell
53,592
-775
-1% -$39.5K 1.87% 8
2022
Q1
$2.81M Buy
54,367
+529
+1% +$27.4K 1.55% 12
2021
Q4
$3.18M Buy
+53,838
New +$2.67M 1.68% 10

Other funds holding PFE

Tyler-Stone Wealth Management's PFE Position: Q2 2025 in Review

Tyler-Stone Wealth Management reduced its Pfizer (PFE) stake by 2.5% in Q2 2025, selling an estimated $39.2K and leaving 64,772 shares worth $1.57M. The position accounts for 0.25% of the portfolio, ranked #77.

Tyler-Stone Wealth Management first reported a position in PFE in Q4 2021 and has held it in 14 quarters since. The position peaked at $3.18M in Q4 2021. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

  • Tyler-Stone Wealth Management held 64,772 shares of Pfizer worth $1.57M as of Q2 2025.
  • Tyler-Stone Wealth Management sold 1,681 Pfizer shares in Q2 2025, an estimated $39.2K.
  • Pfizer made up 0.25% of Tyler-Stone Wealth Management's portfolio in Q2 2025, its #77 holding.
  • Tyler-Stone Wealth Management first reported a position in Pfizer in Q4 2021 and has held it in 14 quarters since.
  • Tyler-Stone Wealth Management's Pfizer position peaked at $3.18M in Q4 2021.
  • 2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on Tyler-Stone Wealth Management's 13F filing for Q2 2025, filed 18 Aug 2025.